Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Consider benefits and risks of new alopecia treatments for safety.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Carboxytherapy may help increase hair growth in alopecia patients but requires ongoing treatment.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

PRP therapy improves hair density and thickness in AGA patients, even with other treatments.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Micrografts promote hair growth in androgenetic alopecia treatment.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Ketoconazole shampoo is a safe and effective treatment for scalp seborrheic dermatitis.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Human hair varies widely and should be classified by curl type rather than race.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Injections with 0.5% minoxidil effectively treat female hair loss, increasing hair density and thickness.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Hair loss can be reversed or even cured using advanced hair restoration techniques, with rare complications like swelling and bleeding.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Frontal fibrosing alopecia can sometimes look like syphilitic hair loss.